Organogenesis Holdings Inc (ORGO)
4.00
-0.43
(-9.71%)
USD |
NASDAQ |
Nov 14, 16:00
4.00
0.00 (0.00%)
After-Hours: 16:47
Organogenesis Holdings Max Drawdown (5Y): 98.74% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.74% |
| September 30, 2024 | 98.74% |
| August 31, 2024 | 98.74% |
| July 31, 2024 | 98.74% |
| June 30, 2024 | 98.74% |
| May 31, 2024 | 98.74% |
| April 30, 2024 | 98.74% |
| March 31, 2024 | 98.74% |
| February 29, 2024 | 98.74% |
| January 31, 2024 | 98.74% |
| December 31, 2023 | 98.74% |
| November 30, 2023 | 98.74% |
| October 31, 2023 | 98.74% |
| September 30, 2023 | 98.74% |
| August 31, 2023 | 98.74% |
| July 31, 2023 | 98.74% |
| June 30, 2023 | 98.74% |
| May 31, 2023 | 98.74% |
| April 30, 2023 | 98.74% |
| March 31, 2023 | 98.74% |
| February 28, 2023 | 98.41% |
| January 31, 2023 | 98.35% |
| December 31, 2022 | 98.35% |
| November 30, 2022 | 98.27% |
| October 31, 2022 | 98.09% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.09% |
| August 31, 2022 | 98.09% |
| July 31, 2022 | 98.09% |
| June 30, 2022 | 98.09% |
| May 31, 2022 | 98.09% |
| April 30, 2022 | 98.09% |
| March 31, 2022 | 98.09% |
| February 28, 2022 | 98.09% |
| January 31, 2022 | 98.09% |
| December 31, 2021 | 98.09% |
| November 30, 2021 | 98.09% |
| October 31, 2021 | 98.09% |
| September 30, 2021 | 98.09% |
| August 31, 2021 | 98.09% |
| July 31, 2021 | 98.09% |
| June 30, 2021 | 98.09% |
| May 31, 2021 | 98.09% |
| April 30, 2021 | 98.09% |
| March 31, 2021 | 98.09% |
| February 28, 2021 | 98.09% |
| January 31, 2021 | 98.09% |
| December 31, 2020 | 98.09% |
| November 30, 2020 | 98.09% |
| October 31, 2020 | 98.09% |
| September 30, 2020 | 98.09% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.62%
Minimum
Nov 2019
98.74%
Maximum
Mar 2023
98.29%
Average
98.09%
Median
Apr 2020
Max Drawdown (5Y) Benchmarks
| Poseida Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -39.91 |
| Beta (5Y) | 1.596 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 78.25% |
| Historical Sharpe Ratio (5Y) | -0.2468 |
| Historical Sortino (5Y) | -0.5895 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.04% |